{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T14:24:47Z","timestamp":1790605487622,"version":"4.1.0"},"reference-count":88,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T00:00:00Z","timestamp":1738627200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011748","name":"Phospholipid Research Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011748","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["MMG-2021-092\/1-1"],"award-info":[{"award-number":["MMG-2021-092\/1-1"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["UIDP\/00645\/2020"],"award-info":[{"award-number":["UIDP\/00645\/2020"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["UIDB\/00645\/2020"],"award-info":[{"award-number":["UIDB\/00645\/2020"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["UIDB\/04138\/2020"],"award-info":[{"award-number":["UIDB\/04138\/2020"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["UIDP\/04138\/2020"],"award-info":[{"award-number":["UIDP\/04138\/2020"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.jconrel.2025.01.083","type":"journal-article","created":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T03:35:24Z","timestamp":1738985724000},"page":"348-361","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["A step forward on the in vitro and in vivo validation of rifabutin-loaded liposomes for the management of highly virulent MRSA infections"],"prefix":"10.1016","volume":"380","author":[{"given":"Mariana P.","family":"Coelho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacinta O.","family":"Pinho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra N.","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Manuela","family":"Gaspar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2025.01.083_bb0005","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.mib.2020.02.005","article-title":"Staphylococcus aureus bloodstream infections: pathogenesis and regulatory mechanisms","volume":"53","author":"Kwiecinski","year":"2020","journal-title":"Curr. Opin. Microbiol."},{"key":"10.1016\/j.jconrel.2025.01.083_bb0010","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1089\/mdr.2019.0068","article-title":"Morphological and biological characteristics of Staphylococcus aureus biofilm formed in the presence of plasma","volume":"25","author":"Sato","year":"2019","journal-title":"Microb. Drug Resist."},{"key":"10.1016\/j.jconrel.2025.01.083_bb0015","author":"Centers for Disease Control and Prevention (CDC)"},{"key":"10.1016\/j.jconrel.2025.01.083_bb0020","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2023.1195758","article-title":"Prevalence and antibiotic resistance of Staphylococcus aureus associated with a college-aged cohort: life-style factors that contribute to nasal carriage","volume":"13","author":"Congdon","year":"2023","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.jconrel.2025.01.083_bb0025","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2018.33","article-title":"Methicillin-resistant Staphylococcus aureus","volume":"4","author":"Lee","year":"2018","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.jconrel.2025.01.083_bb0030","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s13756-019-0506-6","article-title":"The value of the infection prevention and control nurse led MRSA ward round","volume":"8","author":"Garvey","year":"2019","journal-title":"Antimicrob. Resist. Infect. Control"},{"key":"10.1016\/j.jconrel.2025.01.083_bb0035","doi-asserted-by":"crossref","first-page":"9336","DOI":"10.1038\/s41598-020-66270-9","article-title":"Dynamic contact networks of patients and MRSA spread in hospitals","volume":"10","author":"Rocha","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2025.01.083_bb0040","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2020.00107","article-title":"Prevalence and therapies of antibiotic-resistance in Staphylococcus aureus","volume":"10","author":"Guo","year":"2020","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.jconrel.2025.01.083_bb0045","doi-asserted-by":"crossref","first-page":"7333","DOI":"10.2147\/IJN.S169935","article-title":"A review on nanosystems as an effective approach against infections of Staphylococcus aureus","volume":"13","author":"Zhou","year":"2018","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2025.01.083_bb0050","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1080\/21505594.2021.1878688","article-title":"Pathogenicity and virulence of Staphylococcus aureus","volume":"12","author":"Cheung","year":"2021","journal-title":"Virulence"},{"key":"10.1016\/j.jconrel.2025.01.083_bb0055","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","article-title":"Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis","volume":"399","author":"Murray","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.jconrel.2025.01.083_bb0060","author":"World Health Organization"},{"key":"10.1016\/j.jconrel.2025.01.083_bb0065","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3947\/ic.2016.48.4.267","article-title":"Treatment of methicillin-resistant Staphylococcus aureus bacteremia","volume":"48","author":"Choo","year":"2016","journal-title":"Infect. Chemother."},{"key":"10.1016\/j.jconrel.2025.01.083_bb0070","doi-asserted-by":"crossref","first-page":"21391","DOI":"10.1021\/acsomega.3c02239","article-title":"Advances in nanotechnology for biofilm inhibition","volume":"8","author":"Kumar","year":"2023","journal-title":"ACS Omega"},{"key":"10.1016\/j.jconrel.2025.01.083_bb0075","doi-asserted-by":"crossref","first-page":"470","DOI":"10.3390\/ph17040470","article-title":"Liposomal rifabutin\u2014a promising antibiotic repurposing strategy against methicillin-resistant Staphylococcus aureus infections","volume":"17","author":"Pinho","year":"2024","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.jconrel.2025.01.083_bb0080","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3390\/pharmaceutics13030321","article-title":"Liposomes as a nanoplatform to improve the delivery of antibiotics into Staphylococcus aureus biofilms","volume":"13","author":"Ferreira","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2025.01.083_bb0085","doi-asserted-by":"crossref","first-page":"5363","DOI":"10.2174\/0929867325666180706101404","article-title":"Recent drug-repurposing-driven advances in the discovery of novel antibiotics","volume":"26","author":"Konreddy","year":"2019","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.jconrel.2025.01.083_bb0090","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1208\/s12249-019-1333-z","article-title":"Delivery systems as vital tools in drug repurposing","volume":"20","author":"Czech","year":"2019","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.jconrel.2025.01.083_bb0095","doi-asserted-by":"crossref","first-page":"12842","DOI":"10.1021\/acsami.2c23312","article-title":"Thermosensitive nanotherapeutics for localized photothermal ablation of MRSA-infected osteomyelitis combined with chemotherapy","volume":"15","author":"Zhao","year":"2023","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2025.01.083_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2022.112892","article-title":"In vitro antibacterial activity and in vivo pharmacokinetics of intravenously administered amikacin-loaded liposomes for the management of bacterial septicaemia","volume":"220","author":"Maxwell","year":"2022","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.jconrel.2025.01.083_bb0105","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.3390\/molecules26072047","article-title":"Liposomes as antibiotic delivery systems: a promising nanotechnological strategy against antimicrobial resistance","volume":"26","author":"Ferreira","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.jconrel.2025.01.083_bb0110","doi-asserted-by":"crossref","first-page":"435","DOI":"10.3390\/biomedicines11020435","article-title":"Advancing medicine with lipid-based nanosystems\u2014the successful case of liposomes","volume":"11","author":"Luiz","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.jconrel.2025.01.083_bb0115","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1093\/clinids\/22.Supplement_1.S33","article-title":"Rifabutin in the treatment of Mycobacterium avium complex infection: experience in Europe","volume":"22","author":"Dautzenberg","year":"1996","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jconrel.2025.01.083_bb0120","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1093\/clinids\/22.Supplement_1.S37","article-title":"Rifabutin therapy for disseminated Mycobacterium avium complex infection","volume":"22","author":"Sullam","year":"1996","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jconrel.2025.01.083_bb0125","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1128\/AAC.44.9.2424-2430.2000","article-title":"Therapeutic efficacy of liposomal rifabutin in a Mycobacterium avium model of infection","volume":"44","author":"Gaspar","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jconrel.2025.01.083_bb0130","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ijantimicag.2007.08.008","article-title":"Rifabutin encapsulated in liposomes exhibits increased therapeutic activity in a model of disseminated tuberculosis","volume":"31","author":"Gaspar","year":"2008","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.jconrel.2025.01.083_bb0135","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1080\/17425255.2019.1648432","article-title":"Pharmacokinetic and pharmacodynamic considerations of rifamycin antibiotics for the treatment of tuberculosis","volume":"15","author":"Sekaggya-Wiltshire","year":"2019","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.jconrel.2025.01.083_bb0140","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1093\/jac\/dkw024","article-title":"Rifabutin: where do we stand in 2016?","volume":"71","author":"Crabol","year":"2016","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.jconrel.2025.01.083_bb0145","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2024.1475124","article-title":"Rifabutin: a repurposed antibiotic with high potential against planktonic and biofilm staphylococcal clinical isolates","volume":"15","author":"Ferreira","year":"2024","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.jconrel.2025.01.083_bb0150","doi-asserted-by":"crossref","first-page":"326","DOI":"10.3390\/antibiotics9060326","article-title":"Rifabutin use in Staphylococcus biofilm infections: a case series","volume":"9","author":"Doub","year":"2020","journal-title":"Antibiotics"},{"key":"10.1016\/j.jconrel.2025.01.083_bb0155","series-title":"Meyler\u2019s Side Effects of Drugs","first-page":"132","article-title":"Rifamycins","author":"Aronson","year":"2016"},{"key":"10.1016\/j.jconrel.2025.01.083_bb0160","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1128\/jcm.13.4.754-759.1981","article-title":"Emergence of gentamicin- and methicillin-resistant Staphylococcus aureus strains in New York City hospitals","volume":"13","author":"Schaefler","year":"1981","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jconrel.2025.01.083_bb0165","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1007\/BF02531316","article-title":"Two dimensional thin layer chromatographic separation of polar lipids and determination of phospholipids by phosphorus analysis of spots","volume":"5","author":"Rouser","year":"1970","journal-title":"Lipids"},{"key":"10.1016\/j.jconrel.2025.01.083_bb0170","first-page":"1","article-title":"Nanoformulations of a triazene analogue with specific affinity to human melanoma","volume":"1","author":"Calado","year":"2016","journal-title":"J. Nanosci. Adv. Technol."},{"key":"10.1016\/j.jconrel.2025.01.083_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.114021","article-title":"Preclinical validation of a new hybrid molecule loaded in liposomes for melanoma management","volume":"157","author":"Pinho","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.jconrel.2025.01.083_bb0180","first-page":"112","article-title":"Anti-biofilm activity against Staphylococcus aureus MRSA and MSSA of neolignans and extract of Piper regnellii","volume":"27","author":"Brambilla","year":"2017","journal-title":"Rev. Bras"},{"key":"10.1016\/j.jconrel.2025.01.083_bb0185","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.ijpharm.2016.09.074","article-title":"Can sophorolipids prevent biofilm formation on silicone catheter tubes?","volume":"513","author":"Pontes","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2025.01.083_bb0190","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1093\/jac\/dkz223","article-title":"The mechanism of action of pepR, a viral-derived peptide, against Staphylococcus aureus biofilms","volume":"74","author":"Pinto","year":"2019","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.jconrel.2025.01.083_bb0195","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s12906-019-2519-3","article-title":"Avoiding pitfalls in determining antimicrobial activity of plant extracts and publishing the results","volume":"19","author":"Eloff","year":"2019","journal-title":"BMC Complement. Altern. Med."},{"key":"10.1016\/j.jconrel.2025.01.083_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.ab.2021.114449","article-title":"Resazurin rapid screening for antibacterial activities of organic and inorganic nanoparticles: potential, limitations and precautions","volume":"637","author":"Chakansin","year":"2022","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.jconrel.2025.01.083_bb0205","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.3390\/nano12132164","article-title":"Validation of a standard luminescence method for the fast determination of the antimicrobial activity of nanoparticles in Escherichia coli","volume":"12","author":"Marcelo","year":"2022","journal-title":"Nanomaterials"},{"key":"10.1016\/j.jconrel.2025.01.083_bb0210","doi-asserted-by":"crossref","first-page":"3777","DOI":"10.3390\/molecules25173777","article-title":"Copper(II) complexes with mixed heterocycle ligands as promising antibacterial and antitumor species","volume":"25","author":"Rostas","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.jconrel.2025.01.083_bb0215","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1007\/s10637-017-0488-2","article-title":"Copper (II) complexes of bidentate ligands exhibit potent anti-cancer activity regardless of platinum sensitivity status","volume":"35","author":"Wehbe","year":"2017","journal-title":"Investig. New Drugs"},{"key":"10.1016\/j.jconrel.2025.01.083_bb0220","doi-asserted-by":"crossref","first-page":"866","DOI":"10.3390\/pharmaceutics13060866","article-title":"Formulations based on drug loaded aptamer-conjugated liposomes as a viable strategy for the topical treatment of basal cell carcinoma\u2014in vitro tests","volume":"13","author":"Cadinoiu","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2025.01.083_bb0225","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.3390\/polym11091515","article-title":"Aptamer-functionalized liposomes as a potential treatment for basal cell carcinoma","volume":"11","author":"Cadinoiu","year":"2019","journal-title":"Polymers (Basel)"},{"key":"10.1016\/j.jconrel.2025.01.083_bb0230","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1093\/jac\/dkv367","article-title":"In vitro and in vivo activity of a novel sorafenib derivative SC5005 against MRSA","volume":"71","author":"Chang","year":"2016","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.jconrel.2025.01.083_bb0235","doi-asserted-by":"crossref","first-page":"8288","DOI":"10.1039\/C6RA28443D","article-title":"Hydroxybenzylidene-indolinones, c-di-AMP synthase inhibitors, have antibacterial and anti-biofilm activities and also re-sensitize resistant bacteria to methicillin and vancomycin","volume":"7","author":"Opoku-Temeng","year":"2017","journal-title":"RSC Adv."},{"key":"10.1016\/j.jconrel.2025.01.083_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114550","article-title":"Membrane acting Povarov-Doebner derived compounds potently disperse preformed multidrug resistant gram-positive bacterial biofilms","volume":"240","author":"Dayal","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jconrel.2025.01.083_bb0245","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.jmii.2019.08.008","article-title":"Vancomycin-loaded oxidized hyaluronic acid and adipic acid dihydrazide hydrogel: bio-compatibility, drug release, antimicrobial activity, and biofilm model","volume":"53","author":"Liao","year":"2020","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"10.1016\/j.jconrel.2025.01.083_bb0250","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1021\/acsinfecdis.9b00022","article-title":"Inhibitors of intracellular gram-positive bacterial growth synthesized via Povarov\u2013Doebner reactions","volume":"5","author":"Dayal","year":"2019","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.jconrel.2025.01.083_bb0255","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2018.33","article-title":"Methicillin-resistant Staphylococcus aureus","volume":"4","author":"Lee","year":"2018","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.jconrel.2025.01.083_bb0260","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1111\/1469-0691.12651","article-title":"Antimicrobial susceptibility testing in biofilm-growing bacteria","volume":"20","author":"Macia","year":"2014","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.jconrel.2025.01.083_bb0265","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3390\/biom8020029","article-title":"Critical assessment of methods to quantify biofilm growth and evaluate antibiofilm activity of host defence peptides","volume":"8","author":"Haney","year":"2018","journal-title":"Biomolecules"},{"key":"10.1016\/j.jconrel.2025.01.083_bb0270","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.mimet.2007.11.010","article-title":"Comparison of multiple methods for quantification of microbial biofilms grown in microtiter plates","volume":"72","author":"Peeters","year":"2008","journal-title":"J. Microbiol. Methods"},{"key":"10.1016\/j.jconrel.2025.01.083_bb0275","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0008582","article-title":"Population structure of a hybrid clonal group of methicillin-resistant Staphylococcus aureus, ST239-MRSA-III","volume":"5","author":"Smyth","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2025.01.083_bb0280","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0017936","article-title":"A field guide to pandemic, epidemic and sporadic clones of methicillin-resistant Staphylococcus aureus","volume":"6","author":"Monecke","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2025.01.083_bb0285","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.685807","article-title":"Synergistic effect of cefazolin plus fosfomycin against Staphylococcus aureus in vitro and in vivo in an experimental galleria mellonella model","volume":"12","author":"Kussmann","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jconrel.2025.01.083_bb0290","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/s41598-020-80481-0","article-title":"In vitro antagonistic inhibitory effects of palm seed crude oils and their main constituent, lauric acid, with oxacillin in Staphylococcus aureus","volume":"11","author":"Lalouckova","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2025.01.083_bb0295","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0231583","article-title":"Potential combinations of endocannabinoid\/endocannabinoid-like compounds and antibiotics against methicillin-resistant Staphylococcus aureus","volume":"15","author":"Feldman","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2025.01.083_bb0300","doi-asserted-by":"crossref","first-page":"290","DOI":"10.3839\/jksabc.2010.045","article-title":"Antibacterial and synergistic activity of prenylated chalcone isolated from the roots of Sophora flavescens","volume":"53","author":"Lee","year":"2010","journal-title":"J. Korean Soc. Appl. Biol. Chem."},{"key":"10.1016\/j.jconrel.2025.01.083_bb0305","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1086\/381972","article-title":"Clinical relevance of bacteriostatic versus bactericidal mechanisms of action in the treatment of gram-positive bacterial infections","volume":"38","author":"Pankey","year":"2004","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jconrel.2025.01.083_bb0310","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/nprot.2007.521","article-title":"Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances","volume":"3","author":"Wiegand","year":"2008","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.jconrel.2025.01.083_bb0315","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2023.102512","article-title":"Antimicrobial susceptibility testing to evaluate minimum inhibitory concentration values of clinically relevant antibiotics","volume":"4","author":"Barnes","year":"2023","journal-title":"STAR Protoc."},{"key":"10.1016\/j.jconrel.2025.01.083_bb0320","doi-asserted-by":"crossref","first-page":"142","DOI":"10.3390\/pharmaceutics12020142","article-title":"Nanomedicine fight against antibacterial resistance: an overview of the recent pharmaceutical innovations","volume":"12","author":"Eleraky","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2025.01.083_bb0325","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s13346-020-00791-8","article-title":"Lipid-based nanosystems for targeting bone implant-associated infections: current approaches and future endeavors","volume":"11","author":"Ferreira","year":"2021","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.jconrel.2025.01.083_bb0330","doi-asserted-by":"crossref","first-page":"579","DOI":"10.2174\/156802608783955629","article-title":"Developments on drug delivery systems for the treatment of mycobacterial infections","volume":"8","author":"Gaspar","year":"2008","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.jconrel.2025.01.083_bb0335","doi-asserted-by":"crossref","first-page":"373","DOI":"10.2147\/CCID.S141887","article-title":"Efficacy and tolerability of liposomal polyvinylpyrrolidone-iodine hydrogel for the localized treatment of chronic infective, inflammatory, dermatoses: an uncontrolled pilot study","volume":"10","author":"Augustin","year":"2017","journal-title":"Clin. Cosmet. Investig. Dermatol."},{"key":"10.1016\/j.jconrel.2025.01.083_bb0340","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jconrel.2019.12.023","article-title":"The role of liposomes in clinical nanomedicine development. What now? Now what?","volume":"318","author":"Crommelin","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.01.083_bb0345","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2019.00872","article-title":"Lipid-based antimicrobial delivery-systems for the treatment of bacterial infections","volume":"7","author":"Wang","year":"2020","journal-title":"Front. Chem."},{"key":"10.1016\/j.jconrel.2025.01.083_bb0350","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1093\/femsre\/fuz021","article-title":"Impact of nanosystems in Staphylococcus aureus biofilms treatment","volume":"43","author":"Pinto","year":"2019","journal-title":"FEMS Microbiol. Rev."},{"key":"10.1016\/j.jconrel.2025.01.083_bb0355","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1021\/acsinfecdis.9b00357","article-title":"Liposomes for antibiotic encapsulation and delivery","volume":"6","author":"Gonzalez Gomez","year":"2020","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.jconrel.2025.01.083_bb0360","article-title":"The effects of surface properties of liposomes on their activity against Pseudomonas aeruginosa PAO-1 biofilm","volume":"57","author":"Ibaraki","year":"2020","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.jconrel.2025.01.083_bb0365","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1016\/j.bbamem.2012.05.007","article-title":"Molecular structures of fluid phase phosphatidylglycerol bilayers as determined by small angle neutron and X-ray scattering","volume":"1818","author":"Pan","year":"2012","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.jconrel.2025.01.083_bb0370","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.120051","article-title":"Comprehensive analysis of liposome formulation parameters and their influence on encapsulation, stability and drug release in glibenclamide liposomes","volume":"592","author":"Maritim","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2025.01.083_bb0375","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/0005-2736(73)90314-3","article-title":"Phase transitions in phospholipid vesicles fluorescence polarization and permeability measurements concerning the effect of temperature and cholesterol","volume":"311","author":"Papahadjopoulos","year":"1973","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.jconrel.2025.01.083_bb0380","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.3390\/antibiotics12091398","article-title":"LL37-derived fragments improve the antibacterial potential of penicillin G and ampicillin against methicillin-resistant Staphylococcus aureus","volume":"12","author":"Han","year":"2023","journal-title":"Antibiotics"},{"key":"10.1016\/j.jconrel.2025.01.083_bb0385","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.mimet.2014.02.020","article-title":"Quantification of confocal images of biofilms grown on irregular surfaces","volume":"100","author":"Sommerfeld Ross","year":"2014","journal-title":"J. Microbiol. Methods"},{"key":"10.1016\/j.jconrel.2025.01.083_bb0390","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1081\/LPR-120016195","article-title":"The application of confocal microscopy to the study of liposome adsorption onto bacterial biofilms","volume":"12","author":"Ahmed","year":"2002","journal-title":"J. Liposome Res."},{"key":"10.1016\/j.jconrel.2025.01.083_bb0395","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3390\/pharmaceutics8020018","article-title":"Current trends in development of liposomes for targeting bacterial biofilms","volume":"8","author":"Rukavina","year":"2016","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2025.01.083_bb0400","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0005-2736(96)00099-5","article-title":"The interaction of cationic liposomes with the skin-associated bacterium Staphylococcus epidermidis: effects of ionic strength and temperature","volume":"1283","author":"Sanderson","year":"1996","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.jconrel.2025.01.083_bb0405","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1093\/jac\/dkz223","article-title":"The mechanism of action of pepR, a viral-derived peptide, against Staphylococcus aureus biofilms","volume":"74","author":"Pinto","year":"2019","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.jconrel.2025.01.083_bb0410","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/(SICI)1096-9063(199603)46:3<255::AID-PS345>3.0.CO;2-Y","article-title":"Targeting of cationic liposomes to skin-associated bacteria","volume":"46","author":"Sanderson","year":"1996","journal-title":"Pestic. Sci."},{"key":"10.1016\/j.jconrel.2025.01.083_bb0415","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1093\/jac\/dks212","article-title":"Liposomal encapsulation of vancomycin improves killing of methicillin-resistant Staphylococcus aureus in a murine infection model","volume":"67","author":"Sande","year":"2012","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.jconrel.2025.01.083_bb0420","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1093\/jac\/dkm347","article-title":"Lysostaphin as a treatment for systemic Staphylococcus aureus infection in a mouse model","volume":"60","author":"Kokai-Kun","year":"2007","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.jconrel.2025.01.083_bb0425","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2023.1230568","article-title":"Parathyroid hormone therapy improves MRSA-infected fracture healing in a murine diabetic model","volume":"13","author":"Kwon","year":"2023","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.jconrel.2025.01.083_bb0430","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2210490120","article-title":"Kidney-resident innate-like memory \u03b3\u03b4 T cells control chronic Staphylococcus aureus infection of mice","volume":"120","author":"Bertram","year":"2023","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jconrel.2025.01.083_bb0435","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1080\/01926230701595292","article-title":"Evaluation of organ weights for rodent and non-rodent toxicity studies: a review of regulatory guidelines and a survey of current practices","volume":"35","author":"Michael","year":"2007","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.jconrel.2025.01.083_bb0440","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1080\/01926230701595300","article-title":"Society of toxicologic pathology position paper: organ weight recommendations for toxicology studies","volume":"35","author":"Sellers","year":"2007","journal-title":"Toxicol. Pathol."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925000938?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925000938?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:45:01Z","timestamp":1777509901000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365925000938"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":88,"alternative-id":["S0168365925000938"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.01.083","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A step forward on the in vitro and in vivo validation of rifabutin-loaded liposomes for the management of highly virulent MRSA infections","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.01.083","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}